Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02862522 · ClinicalTrials.gov registry record
Uric Acid Levels and Endothelial Functions
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 229
- Enrollment target
NCT02862522: Completed study, sponsored by Mayo Clinic.
NCT02862522 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 229 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02862522 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 229 participants
- Enrollment target
Study Summary
Uric acid is a risk factor for coronary artery disease (CED) in postmenopausal women but the association with inflammation and coronary microvascular endothelial dysfunction is not well-defined. The aim of this study was to determine the relationship of serum uric acid, inflammatory markers and CED.
Interventions
- OTHER Questionnaire of overall health
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 229 participants |
| Start Date | 1992-01 |
| Est. Completion | 2016-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02862522
The ClinicalTrials.gov registry entry for NCT02862522 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 229 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire of overall health is the first listed.
NCT02862522 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02862522 about?
NCT02862522 is a clinical study titled "Uric Acid Levels and Endothelial Functions". Uric acid is a risk factor for coronary artery disease (CED) in postmenopausal women but the association with inflammation and coronary microvascular endothelial dysfunction is not well-defined. The aim of this study was to determine the relationship of serum uric acid, inflammatory markers and CED.
What is the current status of trial NCT02862522?
This trial is currently completed. The enrollment target is 229 participants. The study started on 1992-01. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02862522?
The interventions under investigation include: Questionnaire of overall health (OTHER).
Who is sponsoring clinical trial NCT02862522?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.